Analyst sees share price upside for UltraCharge
TMT Analytics analyst, Marc Kennis, has initiated coverage on battery technology company, UltraCharge (ASX:UTR) with a buy recommendation and a price target of 9 cents per share, implying upside of 180 per cent to this morning’s opening price of 3.2 cents.
Kennis highlighted the well-documented industry dynamics that are currently driving demand for power storage devices and made the point that this will only accelerate in coming years as the number of electric vehicles increases markedly.
The other aspect he noted was that batteries being used in standard devices such as phones already appear to be outgrowing the necessary capacity required to handle the wide range of uses, effectively necessitating frequent charging which is taking all too long for the average consumer.
Such are the problems being faced by manufacturers of smart technology that even a big player in Samsung had catastrophic outcomes from the explosion of batteries used in its Galaxy Note 7.
UTR’s technology will replace graphite in anodes (negative pole) with a nanotube gel material made from titanium dioxide in lithium batteries. Management believes this has the potential to revolutionise the market for lithium batteries by producing a battery that is safe, fast charging and has a longer lifetime.
However it is an early stage of this company’s development and if considering this stock for your portfolio you should take all public information into account and seek professional financial advice.
The company is well on the way to developing this technology having established a laboratory facility in Israel to conduct nanotube synthesis and fabrication of the nanotube anode. Furthermore, it is discussing supply options with end users in the global battery market.
The recent acquisition of new cathode intellectual property from Israeli company ETV Energy should provide a wider product offering that will open new market opportunities and revenue streams while enhancing UTR’s existing anode solution.
UltraCharge shaping up as an IP licensing play
It would appear that this trend is set to continue as Kennis sees UTR as an aggregator of IP around rechargeable battery technology. This includes current IP around anode technology, but could include other technologies as well.
Commercialisation of UTR’s IP will be focused on value-added licensing of this technology. Kennis expects the company to provide clients with a license to use its technology as well as bringing its electrochemistry process know-how to the table, assisting licensees in bringing UTR’s technology to market quickly.
Given its industry network, UTR would be in an ideal position to provide its licensees with access to potential customers such as electronic vehicle manufacturers, as well as laptop and mobile phone companies.
This would see UTR generating multiple income streams and being just as much a services company as an innovative developer and manufacturer.
Should management be able to position UTR in such a way, it is likely to gain substantial investor support as it serves to partly de-risk the capital intensive technology development side of the business, while generating predictable recurring income from licensing and ongoing services agreements.
Numerous near-term share price catalysts
Kennis said near-term share price catalysts included the execution of commercial deals and agreements with suppliers to the lithium-ion battery industry as well as with battery manufacturers directly.
He also sees the production scale up of titanium dioxide nanotube test materials as enabling UTR to have more prospects testing the technology, effectively expediting the commercial rollout. Kennis anticipates news flow around volume scale up to occur in the ‘next several months’, which is relatively near-term in the tech industry.
He noted that a joint venture agreement with one of the large titanium dioxide manufacturers which would potentially start joint nanotube manufacturing is actively being pursued. One would expect that if UTR could seal such a deal it could be the catalyst for a significant share price rerating.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.